Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Antares

In Idaho, the next generation of US nuclear reactors nears reality

A new era of nuclear power is dawning in the US, with startups Antares, Aalo Atomics, and Valar Atomics achieving critical milestones in developing small modular reactors. These advanced, compact designs promise faster, cheaper, and more versatile nuclear energy, potentially powering everything from military bases to data centers.

The Economic Times

Energy Department says advanced nuclear reactor first to reach critical milestone

The Energy Department says a small nuclear reactor under development at a national lab has reached a crucial milestone that could allow it to produce electricity in the next few years

The Independent UK

"Metamorph isn't about replacing the human voice – it's about expanding what's possible when human creativity meets responsible AI": Antares unveils MetaMorph voice modelling plugin

Equipped with 12 ethically-trained voice models, MetaMorph is designed to transform the timbre of vocals in your DAW without relying on cloud-based processing

MusicRadar

From analysis to the latest developments in health,
read the most diverse news in one place.

"We’ve taken what artists love about AutoTune and rebuilt it for a new generation of creators": Antares announces AutoTune 2026 – and discontinues Artist and Access editions

Equipped with an optimized vocal tuning algorithm, Antares says the plugin represents "the most significant update in the software's history"

MusicRadar

"I've never sung with no tuning before – this is really scary": PinkPantheress almost pulled out of Tiny Desk concert after being told she couldn't use Auto-Tune

The NPR show marked the artist's first ever performance without vocal pitch-correction

MusicRadar

"It’s simple enough to create the perfect hard-tuned and harmonised effects within our DAW, providing you have the right software": How to harness hard-tuned vocals

That hard-tuned, robot-like sound, first popularised by Cher, has now become something of a staple in modern pop

MusicRadar

Issue 337 of Computer Music is on sale now

Computer Music 337 issue is out now! With features including:• An in-depth Logic Pro 11 deep-dive – is it worth the upgrade? • Free Excite Audio Lifeline Lite Bundle worth £79 • INTERVIEWED: Iglooghost and Music Producers Guild Awards-winning producer Amy Sergeant • Jack Antonoff's production secrets • Charlotte de…

MusicRadar

Read news from The Economist, FT, and more,
with one subscription

"It’s simple enough to create the perfect hard-tuned and harmonised effects within our DAW, providing you have the right software": How to harness hard-tuned vocals

That hard-tuned, robot-like sound, first popularised by Cher, has now become something of a staple in modern pop

MusicRadar

Antares' Auto-Tune Pro can now do four-part harmonies in real-time with your MIDI keyboard

Released this week, the latest version of Auto-Tune Pro can layer up to four notes of tuned vocal simultaneously in response to MIDI input

MusicRadar

6 "wrong" production techniques that turned out right

We round up six examples of how ignoring conventional studio wisdom can lead to fantastic musical results

MusicRadar

Antares’ Vocal Reverb plugin promises to make your singing sound all the sweeter (with a little help from AI, of course)

It also uses Auto-Tune pitchtracking to tune-up your tails

MusicRadar

LPCN: First Quarter 2022 Financial and Operational Results

By John Vandermosten, CFA NASDAQ:LPCN READ THE FULL LPCN RESEARCH REPORT

Benzinga

Why Antares Pharma Stock Is Soaring Today

Antares Pharma Inc (NASDAQ: ATRS) shares are trading higher Wednesday after the company announced it will be acquired by Halozyme Therapeutics Inc (NASDAQ: HALO) for $5.60 per share in cash, valuing Antares at

Benzinga

The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Halozyme Buys Specialty Product Company Antares In $960M Deal

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Halozyme Buys Antares In $960M Deal To Create One Drug Delivery, Specialty Product Entity

Halozyme Therapeutics Inc (NASDAQ:HALO) will acquire Antares Pharma Inc (NASDAQ:ATRS) for $5.60 per share, valuing Antares at approximately $960 million. The transaction is expected to be accretive to Halozyme's 2022 revenue and adjusted earnings and accelerate top-and bottom-line growth through 2027, with multiple growth drivers beyond 2027. Antares' suite of FDA-approved and partner products utilizing…

Benzinga

Antares Pharma's Oral Testosterone Treatment Scores FDA Approval

Antares Pharma Inc (NASDAQ:ATRS) has nabbed another FDA approval, and the Company's second involving testosterone. The Company announced FDA approval for Tlando (testosterone undecanoate), an oral treatment for testosterone replacement therapy indicated for deficiency or absence of endogenous testosterone or hypogonadism. The first time the Company got a testosterone product approved by…

Benzinga

The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

LPCN: 2021 Results

By John Vandermosten, CFA NASDAQ:LPCN READ THE FULL LPCN RESEARCH REPORT

Get all your
news in one place.

100's of premium titles.
One news app.

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Food and Drug Administration

the Energy Department

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.